G696-5903 Screening compound: 3-[(E)-{[4-(2,5-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid

G696-5903 Screening compound: 3-[(E)-{[4-(2,5-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid
G696-5903 Screening compound: 3-[(E)-{[4-(2,5-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound G696-5903
3-[(E)-{[4-(2,5-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G696-5903

Molecular Formula

C28H32N4O2 (C28 H32 N4 O2)

Compound Name

3-[(E)-{[4-(2,5-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid

IUPAC name

3-[(E)-{[4-(25-dimethylphenyl)piperazin-1-yl][(2-phenylethyl)amino]methylidene}amino]benzoic acid

SMILES

Cc1cc(N(CC2)CCN2/C(/NCCc2ccccc2)=N/c2cccc(C(O)=O)c2)c(C)cc1

InChI

InChI=1S/C28H32N4O2/c1-21-11-12-22(2)26(19-21)31-15-17-32(18-16-31)28(29-14-13-23-7-4-3-5-8-23)30-25-10-6-9-24(20-25)27(33)34/h3-12,19-20H,13-18H2,1-2H3,(H,29,30)(H,33,34)

InChI Key

SLEAXLITANCAHY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27151478

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

456.59

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.047

Distribution Coefficient, logD

6.047

Water Solubility, LogSw

-5.36

Polar Surface Area

52.495

Acid Dissociation Constant (pKa)

4.21

Base Dissociation Constant (pKb)

8.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

G696-5903 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Nuclear receptors
  • Proteases

References: we are preparing a list of scientific research reports with G696-5903 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G696-5903?
Check Price and Availability of G696-5903, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G696-5903 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G696-5903
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G696-5903
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G696-5903 available by request